Saline-Filled and Spectrum Breast Implants
Mentor Worldwide, LLC · Decision date Oct 23, 2026
What did the FDA decide?
This 30-Day Notice for Mentor Worldwide, LLC describes a process change on existing packaging equipment for saline-filled and Spectrum breast implants. The stated change is the addition of small size packaging tooling on the existing packaging equipment.
The record does not state which package sizes, tooling dimensions, production lines, or validation activities are involved. The notice is a supplement to PMA P990075, not a new approval of the device system, and the stated purpose is not independent proof of safety or clinical effectiveness.
FDA approval order statement
the addition of small size packaging tooling on the existing packaging equipment
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 23, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P990075/S071
- Regulatory pathway
- PMA supplement
- Applicant
- Mentor Worldwide, LLC
- Product code
- FWM
- Decision code
- OK30
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, breast, inflatable, internal, saline.
- Applicant
- Mentor Worldwide, LLC
- Product code
- FWM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P990075. Subsequent supplements may change the device or its indications.
FDA decision timeline
P990075 · Original PMA
MENTOR CORPORATION SALINE-FILLED AND SPECTRUM (R) MAMMARY PROSTHESES
P990075/S071 received
Application receipt date recorded by FDA.
P990075/S070 · Related supplement
MENTOR CORPORATION SALINE-FILLED AND SPECTRUM (R) MAMMARY PROSTHESES
P990075/S071 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P990075. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P990075
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Mentor Worldwide, LLC | PMA approval | May 10, 2000 | FDA | |
| Mentor Worldwide, LLC | PMA supplement | Oct 21, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Mentor Worldwide, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 33 Technology Dr., Irvin, CA, 92618
Sources and methodology
- Original FDA record: P990075/S071
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
